Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca
about
Chemotherapy for nasopharyngeal carcinomaEmerging treatment options for nasopharyngeal carcinomaRole of chemotherapy in nasopharyngeal carcinomaWhat Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapyBrachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.Current management strategy of nasopharyngeal carcinoma.Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysisPresent status of management of nasopharyngeal carcinoma.Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy.Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma.State-of-the-art management of nasopharyngeal carcinoma: current and future directionsRole of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative RadiotherapySurrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.Current and emerging treatment options for nasopharyngeal carcinoma.Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trialsInduction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis.Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched StudyRandomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.Induction Chemotherapy Improved Long-term Outcomes of Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Analysis of 5-year Survival Outcomes in the Era of Intensity-modulated Radiotherapy.Controversies and challenges in the current management of nasopharyngeal cancer.Role of chemotherapy in stage IIb nasopharyngeal carcinomaInduction Chemotherapy Has No Prognostic Value in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Chronic Hepatitis B Infection in the IMRT Era.Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.Decreased Overall and Cancer-Specific Mortality with Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Treated by Intensity-modulated Radiotherapy: Multivariate Competing Risk Analysis.Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 cases.Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma.A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience.Comparing the efficacy of induction-concurrent with concurrent-adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis.Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.
P2860
Q24250146-7B87B603-1C51-483B-B304-10CE9F68C962Q26995560-C7BA7136-1372-451D-A3C0-A627EEC164C8Q27022454-9E49F207-3AD5-4A06-B7B5-FBEED5FF1100Q31146986-6C33EC58-51CD-4DF7-AF79-05D5267EAC60Q33346719-D0CD42E2-B698-4449-A182-54C9A4FDAFBBQ33439337-E6A41B68-0E3E-4B88-9238-FDCF9ABEB289Q33579689-5800E6AB-780C-4610-977B-6FD0399CAE5EQ33602326-78F479B3-83B3-43D4-8443-8E18EE86DE56Q33764579-2ACC7378-74F8-4854-9010-ED0B997201B6Q33889391-2F523EA2-4A2A-4EC9-B082-40B7E42BBF4DQ34734273-CA6D3E4E-E1EF-433E-BADF-FBA590AB3695Q35823316-AE0EAB40-B6CB-43E2-873B-CB1A4A0E0CA6Q35824278-139A499F-E5D1-4944-9797-2CAD43E13D80Q35942191-01BE6B96-DBE5-4A39-8C9C-0EB092527690Q36043428-C10B523D-EAD3-4A53-B2A3-BEFB166F7255Q36065641-2F453355-CA13-4BD7-8350-D6DBF167FDB4Q36187049-09426DC1-34CA-44B0-860B-466F64DEB750Q36215439-F45D0566-C37E-4849-8452-5774D1CE21C6Q36359374-ADED8023-3368-4886-B3FC-17AC16A1FC92Q36407458-64995752-D109-452C-9ABA-4BA8D0CB1CE5Q36450771-5167D0EC-BD50-4C7D-A0BB-9DCAFC14D95AQ36621526-EB21E9B8-37FA-4C27-AFDD-5C96A1A60D92Q37133656-09FEA0F7-8EC3-4766-9A5C-55C4CDE9EC56Q37221893-15EEB08F-71D9-4B0B-8107-D46C156F767DQ37353983-32978884-08B0-44A6-A969-E2512BDB4C4BQ37425889-FFE80268-CFA7-4C11-9251-C4B4B3B7E423Q37675943-C2FA6638-BC38-4B2A-828A-03315337A543Q37788242-112F26FB-F598-4742-A840-2AA47D22524EQ38024880-0455C829-00BA-4D5F-B716-F9B510B9A2F8Q40069249-A3D59C37-9BD4-4E82-A166-E5AEFFF10AEFQ40680191-E50214DA-C219-4823-AC79-5F019CD8E032Q41242545-1014956C-7A11-45ED-BF39-5A2C58DCB849Q41721746-F853D6A5-CC96-4C45-A370-E05DB2C71F3CQ43632373-436937AE-BE6B-489C-BE5A-FE8F643388C9Q43861071-9916A64A-FA46-487C-B8BD-A252AA0E903CQ43947669-141F55B8-3E24-4C69-BC09-E4AD8BA74AB0Q43986816-83724058-2889-47A5-9658-E3765A41C746Q44193454-EFFBB2EC-1E39-419B-A589-25BC991F38D9Q45814922-DF996AEE-6812-4E2F-9413-5A8C080BFE92Q46721131-B85C988D-A77B-49D7-B952-A00D9438D432
P2860
Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Preliminary report of the Asia ...... lly advanced nasopharyngeal ca
@en
type
label
Preliminary report of the Asia ...... lly advanced nasopharyngeal ca
@en
prefLabel
Preliminary report of the Asia ...... lly advanced nasopharyngeal ca
@en
P2093
P1433
P1476
Preliminary report of the Asia ...... lly advanced nasopharyngeal ca
@en
P2093
Cheirsilpa A
Lorvidhaya V
Reksodiputro AH
Sumitsawan Y
Thongprasert S
Vootiprux V
P304
P356
10.1002/(SICI)1097-0142(19981201)83:11<2270::AID-CNCR6>3.3.CO;2-K
P407
P577
1998-12-01T00:00:00Z